Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits

American Journal of Respiratory Cell and Molecular Biology

Volumn 48, Issue 1, 2013, Pages 44-52

  Karandashova, Sophia ^a   Florova, Galina ^a   Azghani, Ali O ^b   Komissarov, Andrey A ^a   Koenig, Kathy ^a   Tucker, Torry A ^a   Allen, Timothy C ^a   Stewart, Kris ^a   Tvinnereim, Amy ^a   Idell, Steven ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF TEXAS AT TYLER   (United States)

Author keywords

Intrapleural fibrinolytic therapy; Plasminogen activator inhibitor 1; Pleural injury

Indexed keywords

BETA GALACTOSIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TETRACYCLINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TOLERABILITY; FIBRINOLYTIC THERAPY; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG LAVAGE; MESOTHELIUM CELL; NONHUMAN; PLASMINOGEN ACTIVATION; PLEURA EFFUSION; PLEURA FLUID; PLEURAL FIBROSIS; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; EPITHELIUM; GENE EXPRESSION; HUMANS; LAC OPERON; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLEURA; RABBITS; RECOMBINANT PROTEINS; TETRACYCLINE; THROMBOLYTIC THERAPY; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS; ORYCTOLAGUS CUNICULUS;

EID: 84871894938     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0183OC     Document Type: Article

References (45)

1. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011;66:663-668.
2. Strachan RE, Cornelius A, Gilbert GL, Gulliver T, Martin A, McDonald T, Nixon GM, Roseby R, Ranganathan S, Selvadurai H, et al. Bacterial causes of empyema in children, Australia, 2007-2009. Emerg Infect Dis 2011;17:1839-1845.
3. Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J 2008;15:85-89. (Pubitemid 351676396)
4. Obando I, Munoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, Dhillon SS, Esteva C, Hernandez-Bou S, Garcia-Garcia JJ, et al. Pediatric parapneumonic empyema, Spain. Emerg Infect Dis 2008;14:1390-1397.
5. Roxburgh CS, Youngson GG, Townend JA, Turner SW. Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child 2008;93:316-318. (Pubitemid 352025830)
6. Anthonisen NR. Empyema. Can Respir J 2008;15:69-70. (Pubitemid 351676394)
7. Davies HE, Davies RJ, Davies CW. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65:ii41-ii53.
8. Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med 2004;25:141-153. (Pubitemid 38296339)
9. Decologne N, Kolb M, Margetts PJ, Menetrier F, Artur Y, Garrido C, Gauldie J, Camus P, Bonniaud P. TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol 2007;179:6043-6051.
10. Mutsaers SE, Prele CM, Brody AR, Idell S. Pathogenesis of pleural fibrosis. Respirology 2004;9:428-440. (Pubitemid 40179747)
11. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations J Clin Invest 1949;28:173-190.
12. Idell S. Update on the use of fibrinolysins in pleural disease, 12th edition. Philadelphia, PA: Lippincott, Williams and Wilkins; 2005. pp. 184-190.
13. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-874. (Pubitemid 40300295)
14. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011;365:518-526.
15. Sonnappa S, Cohen G, Owens CM, van Doorn C, Cairns J, Stanojevic S, Elliott MJ, Jaffe A. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006;174:221-227. (Pubitemid 44015396)
16. Sonnappa S, Jaffe A. Treatment approaches for empyema in children. Paediatr Respir Rev 2007;8:164-170. (Pubitemid 46893989)
17. Stefanutti G, Ghirardo V, Barbato A, Gamba P. Evaluation of a pediatric protocol of intrapleural urokinase for pleural empyema: a prospective study. Surgery 2010;148:589-594.
18. Chung CL, Chen YC, Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 2003;123:1188-1195.
19. Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis 1992;95:105-117.
20. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991;144:187-194.
21. Philip-Joet F, Alessi MC, Philip-Joet C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 1995;8:1352-1356.
22. Iglesias D, Alegre J, Aleman C, Ruiz E, Soriano T, Armadans LI, Segura RM, Angles A, Monasterio J, de Sevilla TF. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J 2005;25:104-109. (Pubitemid 40207738)
23. Komissarov AA, Zhou A, Declerck PJ. Modulation of serpin reaction through stabilization of transient intermediate by ligands bound to alpha-helix F. J Biol Chem 2007;282:26306-26315. (Pubitemid 47443777)
24. Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 1992;7:414-426.
25. Miller EJ, Kajikawa O, Pueblitz S, Light RW, Koenig KK, Idell S. Chemokine involvement in tetracycline-induced pleuritis. Eur Respir J 1999;14:1387-1393. (Pubitemid 30019538)
26. Idell S, Pendurthi U, Pueblitz S, Koenig K, Williams T, Rao LV. Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits. Thromb Haemost 1998;79:649-655. (Pubitemid 28120805)
27. Strange C, Baumann MH, Sahn SA, Idell S. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med 1995;151:508-515.
28. Idell S, Mazar A, Cines D, Kuo A, Parry G, Gawlak S, Juarez J, Koenig K, Azghani A, Hadden W, et al. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med 2002;166:920-926. (Pubitemid 35193219)
29. Pretorius E, Humphries P, Ekpo OE, Smit E, van der Merwe CF. Comparative ultrastructural analyses of mouse, rabbit, and human platelets and fibrin networks. microsc res tech 2007;70:823-827.
30. acencio mm, vargas fs, marchi e, carnevale gg, Teixeira LR, Antonangelo L, Broaddus VC. Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis. Lung 2007;185:343-348.
31. Komissarov AA, Mazar AP, Koenig K, Kurdowska AK, Idell S. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2009;297:L568-L577.
32. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84:695-705. (Pubitemid 19197006)
33. Komissarov AA, Florova G, Idell S. Effects of extracellular DNA on plasminogen activation and fibrinolysis. J Biol Chem 2011;286:41949-41962.
34. Midde KK, Batchinsky AI, Cancio LC, Shetty S, Komissarov AA, Florova G, Walker KP III, Koenig K, Chroneos ZC, Allen T, et al. Wood bark smoke induces lung and pleural plasminogen activator inhibitor 1 and stabilizes its MmRNA in porcine lung cells. Shock 2011;36:128-137.
35. Idell S. Anticoagulants for acute respiratory distress syndrome: can they work? Am J Respir Crit Care Med 2001;164:517-520. (Pubitemid 32801651)
36. Idell S, Mazar AP, Bitterman P, Mohla S, Harabin AL. Fibrin turnover in lung inflammation and neoplasia. Am J Respir Crit Care Med 2001;163:578-584. (Pubitemid 32158543)
37. Idell S, Azghani A, Chen S, Koenig K, Mazar A, Kodandapani L, Bdeir K, Cines D, Kulikovskaya I, Allen T. Intrapleural low-molecularweight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits. Exp Lung Res 2007;33:419-440. (Pubitemid 350125562)
38. Idell S, Allen T, Chen S, Koenig K, Mazar A, Azghani A. Intrapleural activation, processing, efficacy, and duration of protection of singlechain urokinase in evolving tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2007;292:L25-L32. (Pubitemid 46103427)
39. Chaillan-Huntington CE, Gettins PGW, Huntington JA, Patston PA. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability. Biochemistry 1997;36:9562-9570. (Pubitemid 27346997)
40. Komissarov AA, Andreasen PA, Declerck PJ, Kamikubo Y, Zhou A, Gruber A. Redirection of the reaction between activated protein C and a serpin to the substrate pathway. Thromb Res 2008;122:397-404. (Pubitemid 351888885)
41. Idell S, Jun NM, Liao H, Gazar AE, Drake W, Lane KB, Koenig K, Komissarov A, Tucker T, Light RW. Single-chain urokinase in empyema induced by Pasturella multocida. Exp Lung Res 2009;35:665-681.
42. Kumar A, Koenig KB, Johnson AR, Idell S. Expression and assembly of procoagulant complexes by human pleural mesothelial cells. Thromb Haemost 1994;71:587-592. (Pubitemid 24132956)
43. Shetty S, Velusamy T, Shetty RS, Marudamuthu AS, Shetty SK, Florova G, Tucker T, Koenig K, Shetty P, Bhandary YP, et al. Post-transcriptional regulation of plasminogen activator inhibitor Type-1 expression in human pleural mesothelial cells. Am J Respir Cell Mol Biol 2010;43:358-367.
44. Lucas A, Dai E, Liu L, Guan H, Nash P, McFadden G, Miller L. Transplant vasculopathy: viral anti-inflammatory serpin regulation of atherogenesis. J Heart Lung Transplant 2000;19:1029-1038.
45. Tucker TA, Williams L, Koenig K, Kothari H, Komissarov AA, Florova G, Mazar AP, Allen TC, Bdeir K, Mohan Rao LV, et al. Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells. Am J Respir Cell Mol Biol 2012;46:196-206.